4,6-Bis(3,5-dichlorophenyl)-2-methylpyrimidine>98.0%(HPLC)(N)1g

3-Amino-6-bromopyrazine-2-carboxamide>98.0%(N)1g

N,N,N',N'-Tetraacetylethylenediamine, 99.0%, 50g

(S)-2-((S)-2-((tert-Butoxycarbonyl)amino)-4-methylpentanamido)-4-methylpentanoic acid, 95.0%, 250mg

(4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)PHENYL)METHANOL, 95%, 5g

tert-butyl 4-sulfamoylpiperidine-1-carboxylate, 95.0%, 5g

4-Boc-6-Amino-1,4-oxazepane, 95.0%, 5g

Elution Tubes ROTI® MIDI in stabilising solution, 1 Piece(s)

anti-DDDDK-tag mouse monoclonal, AP1501, 100 µg

Dimethylglyoxime, min. 99%, pa ACS, 500 g, plastic packaging.

(R)-6-Fluoroindan-1-ylamine hydrochloride, 95.0%, 1g

potassium trifluoro[(3-methylphenyl)methyl]boranuide, 95%, 100mg

Bis(2-ethylhexyl) Itaconate (stabilized with HQ)>94.0%(GC)25mL